Metraipolis › archive › dc_76fb5ef2c481

Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum — Europe PMC PMID:42222167

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42222167
DOI: 10.3389/fphar.2026.1752204
License (as archived): solo-consultazione
Archived: 2026-11-01T16:26:28.805Z
SHA-256 of the archived text: ba94b2e35234f7e0880cf8f2e0f42412716395c895bdc7da0a5fdfdedfe1c3e2
Stable URL of this page: https://metraipolis.com/documento/dc_76fb5ef2c481

How to cite

Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum — Europe PMC PMID:42222167 — Europe PMC (en), https://europepmc.org/article/MED/42222167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76fb5ef2c481 (Metraipolis archive dc_76fb5ef2c481, sha256 ba94b2e35234f7e0880cf8f2e0f42412716395c895bdc7da0a5fdfdedfe1c3e2)

BibTeX

@misc{dc76fb5ef2c481,
  title = {Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum — Europe PMC PMID:42222167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76fb5ef2c481; sha256 ba94b2e35234f7e0880cf8f2e0f42412716395c895bdc7da0a5fdfdedfe1c3e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222167. Agents can read the archived copy with the MCP tool read_document.